CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q2 2020 13F Holders as of 6/30/2020

Type / Class
Equity / NAMEN AKT
Number of holders
265
Total Shares
38.3M
Shares change
+3.37M
Total reported value, excl. options
$2.81B
Value change
+$281M
Put/Call ratio
1.19
Number of buys
146
Number of sells
-96
Price
$73.49
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.